Brief: Tianjin Development To Subscribe For Wealth Management Products
March 1 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCTS IN AN
AGGREGATE
SUBSCRIPTION AMOUNT OF RMB350 MILLION
* TIANJIN DEVELOPMENT -LISHENG PHARMACEUTICAL AND CENTRAL
PHARMACEUTICAL TO SUBSCRIBE FOR INDUSTRIAL BANK WEALTH
MANAGEMENT PRODUCT WORTH RMB350 MILLION
Source text for Eikon: ID:nHKS1tGXx9
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln